Indication
Angiocentric Glioma
2 clinical trials
5 products
Clinical trial
An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabrafenib) and/or Mekinist (Trametinib)Status: Recruiting, Estimated PCD: 2026-05-29
Product
trametinibProduct
dabrafenibProduct
CarboplatinClinical trial
Phase II Open-label Global Study to Evaluate the Effect of Dabrafenib in Combination With Trametinib in Children and Adolescent Patients With BRAF V600 Mutation Positive Low Grade Glioma (LGG) or Relapsed or Refractory High Grade Glioma (HGG)Status: Completed, Estimated PCD: 2021-08-23
Product
VincristineProduct
Dabrafenib